Anemia as a prognostic factor in a population hospitalized due to decompensated heart failure;Anemia como fator prognóstico em uma população hospitalizada por insuficiência cardíaca descompensada

Arquivos Brasileiros de Cardiologia

Volumn 84, Issue 3, 2005, Pages 237-240

  Sales, Ana Luíza F ^a,b   Villacorta, Humberto ^a,b,c   Reis, Leandro ^a,b   Mesquita, Evandro Tinoco ^a,b  

^a Universidade Federal Fluminense ^*

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c NONE   (Brazil)

Author keywords

Anemia; Heart failure; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HOSPITAL PATIENT; HUMAN; HYPONATREMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY;

EID: 17744386351     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. McAlister FA, Teo KK, Taher M et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J 1999; 138: 87-94.
2. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 83: 596-602.
3. McCullough PA, Philbin EF, Spertus JE et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) Study. J Am Coll Cardiol 2002; 39: 60-9.
4. Kosiborod M, Smith GL, Radford MJ et al. The prognostic importance of anemia in patients with heart failure. Am J Med 2003; 114: 112-9.
5. Horwich TB, Fonarow GC, Hamilton MA et al. Anemia is associated with worse symptoms, greater impairment in function capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39: 1780-6.
6. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Sarnak MJ. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll 2002; 38: 955-62.
7. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223-5.
8. Ezekowitz JÁ, McAlister FA, Armstrong PW et al. Anemia is linked to increased mortality in congestive heart failure, but only among men. Canadian Cardiovascular Congress. Toronto, Canadá 2003 (abstract).
9. McClellan WM, Flanders WD, Langston RD et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002; 13: 1928-36.
10. Silverberg DS, Wexler D, Blum M et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35: 1737-44.
11. Silverberg DS, Wexler D, Sheps D et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001; 37: 1775-80.
12. Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003; 107: 294-9.